Travere Therapeutics (TVTX) DMA 200 (2013 - 2026)

Travere Therapeutics (TVTX) DMA 200 (2013 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 200
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	3.89
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	136.77
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	8.11
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	25.76
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	16.36
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	4.45
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	9.62
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	438.42
9	Abivax	90.15 Bn	90.15 Bn	-	110.64
10	Travere Therapeutics	4.78 Bn	4.70 Bn	102.38 Mn	32.89

Download Data